Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 131 results found. Search for [ moderna coronavirus vaccine ]

Results 1 to 21 of 131
PB Jayakumar
New Delhi, July 3, 2020
Industry experts say this could be only an aspirational target and directive to speed up the trials, than a realistic move to get the vaccine launched within one and a half months


BusinessToday.In
July 3, 2020
Coronavirus vaccine update: A coronavirus vaccine candidate tested by American firm Pfizer and German biotech major BioNTech SE has been found to generate antibodies in people, a study showed


BusinessToday.In
July 3, 2020
Coronavirus vaccine update: The DCGI approved the vaccine candidate for human trials after Zydus Cadila's candidate was found to be safe. The company is likely to start enrolment of subjects soon


BusinessToday.In
July 2, 2020
Kerala State Drugs and Pharmaceuticals (KSDP) expects to start production of ventilators by July-end after getting approval from Kerala Government and ICMR


BusinessToday.In
July 2, 2020
Coronavirus Vaccine Latest News: With the news of the Oxford University-AstraZeneca vaccine in its last stage of clinical trials, hopes are high for an earlier than expected arrival of a COVID-19 vaccine


Reuters
July 2, 2020
BioNTech said testing of two dosages of its BNT162b1 drug on 24 healthy volunteers showed that after 28 days they had developed higher levels of COVID-19 antibodies than typically seen in infected people


BusinessToday.In
July 1, 2020
Remdesivir supply: US Department of Health and Human Services said it has secured 500,000 treatment courses of remdesivir for American hospitals through September


E Kumar Sharma
July 1, 2020
Bharat Biotech isn't committing a timeline, but considering the necessary processes, and if COVAXIN does not fail at any stage, the earliest it could hit the market is late 2021


BusinessToday.In
June 30, 2020
Coronavirus vaccine update: The Hyderabad-based vaccine major's vaccine candidate COVAXIN has received permission for advancing to human trials


E Kumar Sharma
June 29, 2020
DCGI has allowed Bharat Biotech to conduct phase I and II human trials for COVAXIN that will begin in July; a finished vaccine is expected to be rolled out in 3-4 months if all goes according to plan


BusinessToday.In
New Delhi, June 29, 2020
Maharashtra government intends to save lives of some 500 critical COVID-19 patients through project PLATINA, the world's largest convalescent plasma therapy trial-cum-project


BusinessToday.In
New Delhi, June 29, 2020
Maharashtra lockdown extension: Moreover, 77 police personnel have been found positive for coronavirus and two succumbed to the disease in the state in the last 24 hours


BusinessToday.In
June 29, 2020
With the news of the Oxford University-AstraZeneca vaccine in its last-stage trial, the world is hopeful of an earlier than expected arrival of a COVID-19 vaccine


Rupa Burman Roy
June 29, 2020
AstraZeneca Pharma India stock has gained 9.9% in one week, 17% in one month and 35% since the beginning of the year.


BusinessToday.In
June 29, 2020
Stock Market LIVE Updates on June 29: Bajaj Finance, followed by Axis Bank, IndusInd Bank, ICICI Bank, SBI, HDFC duo and Infosys were among the top losers in the Sensex pack today. On the other hand, ITC, Sun Pharma, Nestle India and PowerGrid were among the gainers


BusinessToday.In
New Delhi, June 28, 2020
While the general opinion of most experts and pharmaceutical companies is that a corona vaccine would be ready by mid-2021, researchers are still hoping for a 2020 breakthrough


BusinessToday.In
June 27, 2020
In a virtual media conference, Swaminathan stated that AstraZeneca's coronavirus vaccine candidate is the most advanced vaccine currently in terms of development, she said


BusinessToday.In
New Delhi, June 26, 2020
Coronavirus vaccine update: Moderna has signed a deal with Catalent for large-scale manufacturing of its vaccine candidate. Catalent will provide vial filling and packaging capacity as well as additional workforce required for 24X7 manufacturing operations.


BusinessToday.In
New Delhi, June 25, 2020
Coronavirus vaccine news: Johnson and Johnson has expedited its trials for the COVID vaccine. The final stage of the trial expected to begin in September has been pushed up to the second half of July


Reuters
June 25, 2020
Even with no existing approved vaccines, CEPI is already getting manufacturing and supply chains lined up in a quest to ensure coronavirus vaccines are distributed equitably around the globe


PAGES 1 OF 7  12345